NSE:NOVARTIND
Novartis India Limited · NSE · Healthcare · INR · FY for 2026
Figures on this page computed 2026-11-06 22:20 UTC
Last close
n/aINR
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
45.4xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
- Computed from the filing for 2026
43.2%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
26.3%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
23.8%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.004Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
1.5%Dividend yield
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
Price is the furthest below its sector's middle: 0.14 against 0.36 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2026
- Sales0.84x
Its own average over 10 years, 4.24B.
- Profit1.56x
Its own average over 10 years, 597.2M.
- Free cash flow4.97x
Its own average over 10 years, 169.8M.
- Debt0.12x
Its own average over 7 years, 273.6M.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 4.97 times.
The filed years, as a table
10Each line is 100 at 2017-03-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2017-03-31 | 100.0 | 100.0 | 100.0 |
| 2018-03-31 | 84.8 | 136.9 | 92.0 |
| 2019-03-31 | 73.9 | 90.5 | 82.4 |
| 2020-03-31 | 67.5 | 17.6 | 82.4 |
| 2021-03-31 | 62.6 | 36.5 | 82.4 |
| 2022-03-31 | 65.6 | -6.5 | 82.4 |
| 2023-03-31 | 62.1 | 180.6 | 82.4 |
| 2024-03-31 | 55.0 | 148.9 | 82.4 |
| 2025-03-31 | 65.3 | 176.3 | 82.4 |
| 2026-03-31 | 58.1 | 162.8 | 82.4 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
Figures behind the shape
Growth
-1.5%faster is higher, placed against 4,940 companies as of 2026-11-05
Five-year revenue growth rate-1.5%
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
Five-year EPS growth rate34.9%
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
One-year change in net income-7.7%
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
Returns on capital
43.2%higher is higher, placed against 5,079 companies as of 2026-11-05
Return on invested capital43.2%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on equity11.4%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on assets9.5%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Margins
37.5%wider is higher, placed against 3,410 companies as of 2026-11-05
Gross margin37.5%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Operating margin26.0%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Net margin26.3%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Free cash flow margin23.8%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Price
45.4xcheaper is higher, placed against 4,359 companies as of 2026-11-05
Price to earnings45.4x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
- Computed from the filing for 2026
Price to book5.2x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
- Computed from the filing for 2026
- computed
- Computed from the filing for 2026
EV to EBITDA37.9x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Price to sales ratio11.9x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
Safety
0.004safer is higher, placed against 1,435 companies as of 2026-11-05
Debt to equity0.004
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Current ratio5.30
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Interest coverage73.1x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Altman Z-Scoren/a
We do not hold this figure for this company, so there is nothing to place.
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
What it pays out
1.5%more, and better covered, is higher, placed against 1,089 companies as of 2026-11-05
Dividend yield1.5%
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
Payout ratio66.3%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Dividend cover ratio1.4x
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.